Reborn Coffee, Inc. REBN Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001213900-25-046026
cik 1707910
name REBORN COFFEE, INC.
sic 5812
countryba US
stprba CA
cityba BREA
zipba 92821
bas1 580 N. BERRY STREET
bas2
baph 714-784-6369
countryma US
stprma CA
cityma BREA
zipma 92821
mas1 580 N. BERRY STREET
mas2
countryinc US
stprinc DE
ein 474752305
former CAPAX INC.
changed 20170530
afs 4-NON
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250520
accepted 2025-05-20 17:01:00.0
prevrpt 0
detail 1
instance ea0242663-10q_reborn_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001213900-25-046026 20241231 Accrued Liabilities Current 774826.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax 21091.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax 25075.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Additional Paid In Capital 22674095.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Assets 7789123.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Commitments And Contingencies USD 0 us-gaap/2025
0001213900-25-046026 20241231 Common Stock Issuable Value 1470000.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20240331 Cost Of Revenue 20327.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Debt Conversion Converted Instrument Amount1 1000000.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Derivative Expense USD 1 0001213900-25-046026
0001213900-25-046026 20250331 Derivative Expense 395807.0000 USD 1 0001213900-25-046026
0001213900-25-046026 20250331 Earnings Per Share Basic -0.4700 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets 39861.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Interest Expense Nonoperating 181155.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Liabilities And Stockholders Equity 8064577.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Loan Payable Emergency Injury Disaster Loan E I D L Current 30060.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20250331 Loanpayablepayrollprotectionprogram P P P Non Current 26307.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20250331 Loans Payable To Shareholders Current 284581.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20241231 Long Term Loans From Bank USD 0 us-gaap/2025
0001213900-25-046026 20250331 Net Cash Provided By Used In Financing Activities 152302.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Net Cash Provided By Used In Operating Activities 464606.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-046026 20250331 Net Income Loss -2191144.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-046026 20250331 Operating Lease Liability Noncurrent 1537506.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 1 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20241231 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Preferred Stock Shares Outstanding shares 0 us-gaap/2025
0001213900-25-046026 20241231 Property Plant And Equipment Net 3352911.0000 USD 0 us-gaap/2025 Geographical= North America;
0001213900-25-046026 20250331 Property Plant And Equipment Net 733891.0000 USD 0 us-gaap/2025 Geographical= Asia;
0001213900-25-046026 20240331 Repayent Of Loan Payable Public Private Partnership USD 1 0001213900-25-046026
0001213900-25-046026 20250331 Repayments Of Notes Payable 3264481.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Revenues 1518062.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Revenues 153200.0000 USD 1 us-gaap/2025 Geographical= Asia;
0001213900-25-046026 20240331 Revenues 1471654.0000 USD 1 us-gaap/2025 Product Or Service= Stores;
0001213900-25-046026 20241231 Shares Outstanding 4274508.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20231231 Stockholders Equity -16756924.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-046026 20241231 Stockholders Equity 2602742.0000 USD 0 us-gaap/2025
0001213900-25-046026 20240331 Stock Issued During Period Shares Conversion Of Units 983497.0000 shares 1 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20241231 Accounts Receivable Net Current 67309.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Common Stock Issuable Share Issuable 294000.0000 shares 0 0001213900-25-046026
0001213900-25-046026 20250331 Common Stock Issuable Value 1470000.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20250331 Common Stock Shares Outstanding 4274508.0000 shares 0 us-gaap/2025
0001213900-25-046026 20240331 Gain Loss On Termination Of Lease 456.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 General And Administrative Expense 2466254.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Income Tax Expense Benefit USD 1 us-gaap/2025
0001213900-25-046026 20250331 Loan Payable Emergency Injury Disaster Loan E I D L Current 30060.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20241231 Loanpayablepayrollprotectionprogram P P P Non Current 26307.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20241231 Loans Payable To Bank Current 111300.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Loans Payable To Bank Current 349018.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Loans Payable To Shareholders Current 427073.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20241231 Long Term Loans From Bank USD 0 us-gaap/2025 Debt Instrument= Loans Payable To Financial Institutions;
0001213900-25-046026 20240331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20250331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-046026 20240331 Operating Income Loss -863572.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-046026 20250331 Other Nonoperating Income Expense 83882.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Preferred Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Preferred Stock Shares Outstanding shares 0 us-gaap/2025
0001213900-25-046026 20240331 Proceeds From Notes Payable USD 1 us-gaap/2025
0001213900-25-046026 20250331 Proceeds From Repayments Of Other Debt -142492.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Property Plant And Equipment Net 4017002.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Property Plant And Equipment Net 3283111.0000 USD 0 us-gaap/2025 Geographical= North America;
0001213900-25-046026 20250331 Revenues 1693261.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Shares Outstanding 2849671.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20240331 Shares Outstanding shares 0 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20250331 Shares Outstanding 4274508.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20231231 Stockholders Equity USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-046026 20231231 Stockholders Equity USD 0 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20250331 Stockholders Equity 1470000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20250331 Accrued Liabilities Current 546798.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Additional Paid In Capital 22674095.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Allowance For Doubtful Accounts Receivable Current 0.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Assets Current 1556963.0000 USD 0 us-gaap/2025
0001213900-25-046026 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 164301.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Common Stock Issuables Par Value 0.0001 USD 0 0001213900-25-046026
0001213900-25-046026 20250331 Common Stock Shares Authorized 40000000.0000 shares 0 us-gaap/2025
0001213900-25-046026 20250331 Debt Conversion Converted Instrument Amount1 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Debt Instrument Unamortized Discount Current 3142146.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Earnings Per Share Diluted -0.4700 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Gain Loss On Termination Of Lease 15662.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Increase Decrease In Accrued Liabilities 113403.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets 797957.0000 USD 1 us-gaap/2025
0001213900-25-046026 20241231 Inventory Net 169615.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Inventory Net 203082.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Liabilities Current 2783374.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Loans Payable To Bank Current 111300.0000 USD 0 us-gaap/2025 Debt Instrument= Loans Payable To Financial Institutions;
0001213900-25-046026 20240331 Net Cash Provided By Used In Investing Activities -986982.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20250331 Net Income Loss -2191144.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-046026 20240331 Nonoperating Income Expense -126972.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Operating Costs And Expenses 3390618.0000 USD 1 us-gaap/2025
0001213900-25-046026 20241231 Other Assets Noncurrent 193188.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 3984.0000 USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-046026 20250331 Preferred Stock Shares Authorized 1000000.0000 shares 0 us-gaap/2025
0001213900-25-046026 20241231 Preferred Stock Shares Issued shares 0 us-gaap/2025
0001213900-25-046026 20240331 Proceeds From Repayments Of Notes Payable USD 1 us-gaap/2025
0001213900-25-046026 20240331 Proceeds From Sale Of Productive Assets USD 1 us-gaap/2025
0001213900-25-046026 20240331 Repayments Of Short Term Debt 73160.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Revenues 1678935.0000 USD 1 us-gaap/2025 Product Or Service= Stores;
0001213900-25-046026 20231231 Stockholders Equity USD 0 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20240331 Stockholders Equity 15484.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-046026 20240331 Stockholders Equity USD 0 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20241231 Stockholders Equity 22674095.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-046026 20250331 Stockholders Equity USD 0 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20240331 Stock Issued During Period Value Conversion Of Units 2700000.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Stock Issued During Period Value Conversion Of Units USD 1 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20241231 Accounts Payable Current 558444.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Allowance For Doubtful Accounts Receivable Current 0.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Assets Current 862752.0000 USD 0 us-gaap/2025
0001213900-25-046026 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect -94050.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Common Stock Issuables Par Value 0.0001 USD 0 0001213900-25-046026
0001213900-25-046026 20241231 Common Stock Shares Issued 4274508.0000 shares 0 us-gaap/2025
0001213900-25-046026 20250331 Common Stock Value 428.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Cost Of Revenue USD 1 us-gaap/2025
0001213900-25-046026 20250331 Derivative Liabilities Current 3076956.0000 USD 0 us-gaap/2025
0001213900-25-046026 20240331 Income Taxes Paid Net USD 1 us-gaap/2025
0001213900-25-046026 20250331 Income Tax Expense Benefit 707.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Increase Decrease In Accounts Payable -104261.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Increase Decrease In Accounts Receivable 135786.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Increase Decrease In Accounts Receivable 1982.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Increase Decrease In Accrued Liabilities -228028.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Increase Decrease In Derivative Liabilities USD 1 us-gaap/2025
0001213900-25-046026 20250331 Interest Paid Net 39838.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Issuance Of Stock And Warrants For Services Or Claims USD 1 us-gaap/2025
0001213900-25-046026 20241231 Liabilities And Stockholders Equity 7789123.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Loans Payable To Bank Current 349018.0000 USD 0 us-gaap/2025 Debt Instrument= Loans Payable To Financial Institutions;
0001213900-25-046026 20240331 Net Cash Provided By Used In Operating Activities -1933908.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Operating Income Loss -1697357.0000 USD 1 us-gaap/2025
0001213900-25-046026 20241231 Operating Lease Liability Current 844177.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Operating Lease Liability Current 842014.0000 USD 0 us-gaap/2025
0001213900-25-046026 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 15484.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-046026 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 1 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20250331 Preferred Stock Shares Issued shares 0 us-gaap/2025
0001213900-25-046026 20250331 Proceeds From Issuance Of Common Stock USD 1 us-gaap/2025
0001213900-25-046026 20241231 Property Plant And Equipment Net 4080004.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Repayent Of Loan Payable Public Private Partnership 11776.0000 USD 1 0001213900-25-046026
0001213900-25-046026 20240331 Revenues 46408.0000 USD 1 us-gaap/2025 Product Or Service= Wholesale And Online;
0001213900-25-046026 20240331 Right Of Use Asset Obtained In Exchange For Operating Lease Liability 216633.0000 USD 1 us-gaap/2025
0001213900-25-046026 20231231 Shares Outstanding 1866174.0000 shares 0 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20231231 Stockholders Equity 846406.0000 USD 0 us-gaap/2025
0001213900-25-046026 20231231 Stockholders Equity 187.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20250331 Stockholders Equity 22674095.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-046026 20240331 Stock Issued During Period Value Conversion Of Units USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-046026 20250331 Weighted Average Number Of Diluted Shares Outstanding 4616591.0000 shares 1 us-gaap/2025
0001213900-25-046026 20241231 Cash And Cash Equivalents At Carrying Value 158215.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Common Stock Shares Issued 4274508.0000 shares 0 us-gaap/2025
0001213900-25-046026 20250331 Increase Decrease In Derivative Liabilities 2681149.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Interest Expense Nonoperating 134781.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Loan Payable Payroll Protection Program P P P Current 25718.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20250331 Long Term Loans From Bank USD 0 us-gaap/2025
0001213900-25-046026 20250331 Net Cash Provided By Used In Investing Activities 1994.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 15484.0000 USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-046026 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 1 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 1 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20250331 Other Cost And Expense Operating 924364.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Payments To Acquire Property Plant And Equipment 986982.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Payments To Acquire Property Plant And Equipment USD 1 us-gaap/2025
0001213900-25-046026 20250331 Preferred Stock Value USD 0 us-gaap/2025
0001213900-25-046026 20241231 Prepaid Expense And Other Assets Current 467613.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Prepaid Expense And Other Assets Current 507473.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Property Plant And Equipment Net 727093.0000 USD 0 us-gaap/2025 Geographical= Asia;
0001213900-25-046026 20241231 Retained Earnings Accumulated Deficit -21562872.0000 USD 0 us-gaap/2025
0001213900-25-046026 20240331 Stock Issued During Period Value Conversion Of Units 2699902.0000 USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-046026 20240331 Stock Issued During Period Value Conversion Of Units USD 1 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20240331 Weighted Average Number Of Shares Outstanding Basic 1653826.0000 shares 1 us-gaap/2025
0001213900-25-046026 20250331 Retained Earnings Accumulated Deficit -23754016.0000 USD 0 us-gaap/2025
0001213900-25-046026 20240331 Revenues 1364862.0000 USD 1 us-gaap/2025 Geographical= North America;
0001213900-25-046026 20231231 Shares Outstanding shares 0 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20250331 Shares Outstanding shares 0 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20240331 Stockholders Equity USD 0 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20240331 Stockholders Equity -17747468.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-046026 20241231 Stockholders Equity 21091.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-046026 20250331 Proceeds From Repayments Of Notes Payable 237718.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Accounts Receivable Net Current 69291.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Assets 8064577.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 158215.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect 618902.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Common Stock Shares Issuable Per Share 5.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20241231 Common Stock Shares Outstanding 4274508.0000 shares 0 us-gaap/2025
0001213900-25-046026 20241231 Common Stock Value 428.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Convertible Debt Current 191187.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Debt Instrument Unamortized Discount Current 0.0000 USD 0 us-gaap/2025
0001213900-25-046026 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -990544.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Increase Decrease In Accounts Payable -285550.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Issuance Of Stock And Warrants For Services Or Claims 122336.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Liabilities 7648995.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Liabilities Current 5615242.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Loan Payable Emergency Injury Disaster Loan E I D L Current 30060.0000 USD 0 0001213900-25-046026 Debt Instrument= Other Loan Payable;
0001213900-25-046026 20250331 Loan Payable Emergency Injury Disaster Loan Non Current 469940.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20240331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-046026 20250331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20250331 Nonoperating Income Expense -493080.0000 USD 1 us-gaap/2025
0001213900-25-046026 20241231 Operating Lease Right Of Use Asset 2653179.0000 USD 0 us-gaap/2025
0001213900-25-046026 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 1 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20250331 Proceeds From Sale Of Productive Assets 1994.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Repayment Of Borrowings From Shareholder USD 1 0001213900-25-046026
0001213900-25-046026 20240331 Repayments Of Notes Payable USD 1 us-gaap/2025
0001213900-25-046026 20250331 Revenues 1693261.0000 USD 1 us-gaap/2025 Geographical= North America;
0001213900-25-046026 20250331 Right Of Use Asset Obtained In Exchange For Operating Lease Liability 258950.0000 USD 1 us-gaap/2025
0001213900-25-046026 20241231 Shares Outstanding 294000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20241231 Shares Outstanding shares 0 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20231231 Stockholders Equity 17603143.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-046026 20240331 Stockholders Equity 285.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20241231 Stockholders Equity 428.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20250331 Stockholders Equity 25075.0000 USD 0 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-046026 20240331 Stock Issued During Period Shares Conversion Of Units shares 1 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20240331 Stock Issued During Period Value Conversion Of Units USD 1 us-gaap/2025 Equity Components= Accumulated Other Comprehensive Income;
0001213900-25-046026 20250331 Accounts Payable Current 268910.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Cash And Cash Equivalents At Carrying Value 777117.0000 USD 0 us-gaap/2025
0001213900-25-046026 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 70251.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 777117.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Commitments And Contingencies USD 0 us-gaap/2025
0001213900-25-046026 20250331 Common Stock Issuable Share Issuable 294000.0000 shares 0 0001213900-25-046026
0001213900-25-046026 20250331 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Common Stock Shares Authorized 40000000.0000 shares 0 us-gaap/2025
0001213900-25-046026 20250331 Depreciation 61008.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Earnings Per Share Diluted -0.6000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Income Taxes Paid Net USD 1 us-gaap/2025
0001213900-25-046026 20240331 Increase Decrease In Inventories 81637.0000 USD 1 us-gaap/2025
0001213900-25-046026 20241231 Liabilities 5186381.0000 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Loan Payable Emergency Injury Disaster Loan Non Current 469940.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20241231 Loan Payable Payroll Protection Program P P P Current 37494.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20240331 Net Income Loss -990544.0000 USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-046026 20240331 Operating Costs And Expenses 2381634.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Operating Lease Right Of Use Asset 2297424.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Other Assets Noncurrent 193188.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 3984.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 1 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-046026 20240331 Other Cost And Expense Operating 361043.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Other Nonoperating Income Expense 7809.0000 USD 1 us-gaap/2025
0001213900-25-046026 20241231 Preferred Stock Shares Authorized 1000000.0000 shares 0 us-gaap/2025
0001213900-25-046026 20250331 Proceeds From Notes Payable 3333333.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Repayments Of Short Term Debt USD 1 us-gaap/2025
0001213900-25-046026 20231231 Shares Outstanding shares 0 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20250331 Shares Outstanding 294000.0000 shares 0 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20241231 Stockholders Equity USD 0 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20240331 Stock Issued During Period Shares Conversion Of Units shares 1 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2025
0001213900-25-046026 20241231 Common Stock Shares Issuable Per Share 5.0000 USD 0 0001213900-25-046026
0001213900-25-046026 20241231 Convertible Debt Current USD 0 us-gaap/2025
0001213900-25-046026 20240331 Depreciation 63330.0000 USD 1 us-gaap/2025
0001213900-25-046026 20241231 Derivative Liabilities Current USD 0 us-gaap/2025
0001213900-25-046026 20240331 Earnings Per Share Basic -0.6000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 General And Administrative Expense 2000264.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -2190437.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Increase Decrease In Inventories 33467.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Interest Paid Net 134781.0000 USD 1 us-gaap/2025
0001213900-25-046026 20241231 Loan Payable Emergency Injury Disaster Loan E I D L Current 30060.0000 USD 0 0001213900-25-046026 Debt Instrument= Other Loan Payable;
0001213900-25-046026 20250331 Long Term Loans From Bank USD 0 us-gaap/2025 Debt Instrument= Loans Payable To Financial Institutions;
0001213900-25-046026 20240331 Net Cash Provided By Used In Financing Activities 2826840.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Net Income Loss -990544.0000 USD 1 us-gaap/2025
0001213900-25-046026 20250331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20250331 Net Income Loss USD 1 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20241231 Operating Lease Liability Noncurrent 1906760.0000 USD 0 us-gaap/2025
0001213900-25-046026 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax USD 1 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-046026 20241231 Preferred Stock Value USD 0 us-gaap/2025
0001213900-25-046026 20240331 Proceeds From Issuance Of Common Stock 2700000.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Proceeds From Repayments Of Other Debt 100000.0000 USD 1 us-gaap/2025
0001213900-25-046026 20240331 Repayment Of Borrowings From Shareholder 100000.0000 USD 1 0001213900-25-046026
0001213900-25-046026 20250331 Revenues USD 1 us-gaap/2025 Geographical= Asia;
0001213900-25-046026 20250331 Revenues 14326.0000 USD 1 us-gaap/2025 Product Or Service= Wholesale And Online;
0001213900-25-046026 20240331 Shares Outstanding shares 0 us-gaap/2025 Equity Components= Preferred Stock;
0001213900-25-046026 20240331 Stockholders Equity 2571346.0000 USD 0 us-gaap/2025
0001213900-25-046026 20240331 Stockholders Equity 20303045.0000 USD 0 us-gaap/2025 Equity Components= Additional Paid In Capital;
0001213900-25-046026 20241231 Stockholders Equity 1470000.0000 USD 0 us-gaap/2025 Equity Components= Common Stock Issuable;
0001213900-25-046026 20241231 Stockholders Equity -21562872.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-046026 20250331 Stockholders Equity 415582.0000 USD 0 us-gaap/2025
0001213900-25-046026 20250331 Stockholders Equity 428.0000 USD 0 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20250331 Stockholders Equity -23754016.0000 USD 0 us-gaap/2025 Equity Components= Retained Earnings;
0001213900-25-046026 20240331 Stock Issued During Period Value Conversion Of Units 98.0000 USD 1 us-gaap/2025 Equity Components= Common Stock;
0001213900-25-046026 20240331 Weighted Average Number Of Diluted Shares Outstanding 1653826.0000 shares 1 us-gaap/2025
0001213900-25-046026 20250331 Weighted Average Number Of Shares Outstanding Basic 4616591.0000 shares 1 us-gaap/2025

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Operating Lease Liability Noncurrent us-gaap/2025 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Net Cash Provided By Used In Investing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.
Cash And Cash Equivalents At Carrying Value us-gaap/2025 0 0 monetary I D Cash and Cash Equivalent Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Common Stock Shares Authorized us-gaap/2025 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Convertible Debt Current us-gaap/2025 0 0 monetary I C Convertible Debt, Current The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
Earnings Per Share Diluted us-gaap/2025 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Proceeds From Repayments Of Notes Payable us-gaap/2025 0 0 monetary D D Proceeds from (Repayments of) Notes Payable Amount of cash inflow (outflow) from long-term debt supported by a written promise to pay an obligation.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2025 0 0 monetary D D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Proceeds From Issuance Of Common Stock us-gaap/2025 0 0 monetary D D Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity.
Property Plant And Equipment Net us-gaap/2025 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
General And Administrative Expense us-gaap/2025 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Commitments And Contingencies us-gaap/2025 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Additional Paid In Capital us-gaap/2025 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Shares Issued us-gaap/2025 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Increase Decrease In Accounts Payable us-gaap/2025 0 0 monetary D D Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Repayments Of Short Term Debt us-gaap/2025 0 0 monetary D C Repayments of Short-Term Debt The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.
Cost Of Revenue us-gaap/2025 0 0 monetary D D Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period.
Derivative Expense 0001213900-25-046026 1 0 monetary D D Derivative Expense The amount of derivative expense.
Other Cost And Expense Operating us-gaap/2025 0 0 monetary D D Other Cost and Expense, Operating The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.
Operating Income Loss us-gaap/2025 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2025 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Accounts Receivable Net Current us-gaap/2025 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Depreciation us-gaap/2025 0 0 monetary D D Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Operating Costs And Expenses us-gaap/2025 0 0 monetary D D Operating Costs and Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.
Operating Lease Liability Current us-gaap/2025 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Operating Lease Right Of Use Asset us-gaap/2025 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Preferred Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Repayments Of Notes Payable us-gaap/2025 0 0 monetary D C Repayments of Notes Payable The cash outflow for a borrowing supported by a written promise to pay an obligation.
Stock Issued During Period Value Conversion Of Units us-gaap/2025 0 0 monetary D C Stock Issued During Period, Value, Conversion of Units Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).
Common Stock Issuables Par Value 0001213900-25-046026 1 0 perShare I Common Stock Issuables Par Value Common stock issuable, par value.
Common Stock Issuable Value 0001213900-25-046026 1 0 monetary I C Common Stock Issuable Value Common stock issuable, Value.
Loan Payable Payroll Protection Program P P P Current 0001213900-25-046026 1 0 monetary I C Loan Payable Payroll Protection Program PPPCurrent Loan payable, payroll protection program (PPP), current portion.
Loan Payable Emergency Injury Disaster Loan E I D L Current 0001213900-25-046026 1 0 monetary I C Loan Payable Emergency Injury Disaster Loan EIDLCurrent Loan payable, emergency injury disaster loan (EIDL), current portion.
Accrued Liabilities Current us-gaap/2025 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Earnings Per Share Basic us-gaap/2025 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Payments To Acquire Property Plant And Equipment us-gaap/2025 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Shares Outstanding us-gaap/2025 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Debt Instrument Unamortized Discount Current us-gaap/2025 0 0 monetary I D Debt Instrument, Unamortized Discount, Current Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2025 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Long Term Loans From Bank us-gaap/2025 0 0 monetary I C Loans Payable to Bank, Noncurrent Carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the operating cycle if longer, excluding current portion.
Preferred Stock Shares Issued us-gaap/2025 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Proceeds From Repayments Of Other Debt us-gaap/2025 0 0 monetary D D Proceeds from (Repayments of) Other Debt Amount of cash inflow (outflow) for debt classified as other.
Right Of Use Asset Obtained In Exchange For Operating Lease Liability us-gaap/2025 0 0 monetary D D Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Amount of increase in right-of-use asset obtained in exchange for operating lease liability.
Loanpayablepayrollprotectionprogram P P P Non Current 0001213900-25-046026 1 0 monetary I C Loanpayablepayrollprotectionprogram PPPNon Current Loan payable, payroll protection program (PPP), net of current portion.
Loans Payable To Shareholders Current 0001213900-25-046026 1 0 monetary I C Loans Payable To Shareholders Current Represents the amount of loans payable to shareholders, current portion.
Repayent Of Loan Payable Public Private Partnership 0001213900-25-046026 1 0 monetary D C Repayent Of Loan Payable Public Private Partnership The amount represents repayment of loan payable, PPP.
Increase Decrease In Inventories us-gaap/2025 0 0 monetary D C Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Liabilities Current us-gaap/2025 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Net Cash Provided By Used In Financing Activities us-gaap/2025 0 0 monetary D D Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.
Common Stock Shares Outstanding us-gaap/2025 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Loans Payable To Bank Current us-gaap/2025 0 0 monetary I C Loans Payable to Bank, Current Carrying value as of the balance sheet date of current portion of long-term loans payable to bank due within one year or the operating cycle if longer.
Nonoperating Income Expense us-gaap/2025 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Other Assets Noncurrent us-gaap/2025 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Proceeds From Sale Of Productive Assets us-gaap/2025 0 0 monetary D D Proceeds from Sale of Productive Assets The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.
Loan Payable Emergency Injury Disaster Loan Non Current 0001213900-25-046026 1 0 monetary I C Loan Payable Emergency Injury Disaster Loan Non Current The amount of loan payable emergency injury disaster loan.
Assets us-gaap/2025 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Increase Decrease In Accounts Receivable us-gaap/2025 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Liabilities And Stockholders Equity us-gaap/2025 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss us-gaap/2025 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Other Nonoperating Income Expense us-gaap/2025 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Stockholders Equity us-gaap/2025 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Common Stock Par Or Stated Value Per Share us-gaap/2025 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2025 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Interest Expense Nonoperating us-gaap/2025 0 0 monetary D D Interest Expense, Nonoperating Amount of interest expense classified as nonoperating.
Prepaid Expense And Other Assets Current us-gaap/2025 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Increase Decrease In Accrued Liabilities us-gaap/2025 0 0 monetary D D Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
Stock Issued During Period Shares Conversion Of Units us-gaap/2025 0 0 shares D Stock Issued During Period, Shares, Conversion of Units The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).
Common Stock Issuable Share Issuable 0001213900-25-046026 1 0 shares I Common Stock Issuable Share Issuable Number of common stock issuable, shares Issuable.
Increase Decrease In Derivative Liabilities us-gaap/2025 0 0 monetary D D Increase (Decrease) in Derivative Liabilities The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).
Interest Paid Net us-gaap/2025 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activity Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Preferred Stock Shares Authorized us-gaap/2025 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2025 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2025 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Accounts Payable Current us-gaap/2025 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Assets Current us-gaap/2025 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Income Tax Expense Benefit us-gaap/2025 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Inventory Net us-gaap/2025 0 0 monetary I D Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Revenues us-gaap/2025 0 0 monetary D C Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Liabilities us-gaap/2025 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 0 0 monetary I D Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.
Debt Conversion Converted Instrument Amount1 us-gaap/2025 0 0 monetary D C Debt Conversion, Converted Instrument, Amount The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
Preferred Stock Value us-gaap/2025 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Proceeds From Notes Payable us-gaap/2025 0 0 monetary D D Proceeds from Notes Payable The cash inflow from a borrowing supported by a written promise to pay an obligation.
Repayment Of Borrowings From Shareholder 0001213900-25-046026 1 0 monetary D D Repayment Of Borrowings From Shareholder Repayment of borrowings from shareholder.
Net Cash Provided By Used In Operating Activities us-gaap/2025 0 0 monetary D Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.
Retained Earnings Accumulated Deficit us-gaap/2025 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Common Stock Value us-gaap/2025 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Income Taxes Paid Net us-gaap/2025 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Allowance For Doubtful Accounts Receivable Current us-gaap/2025 0 0 monetary I C Accounts Receivable, Allowance for Credit Loss, Current Amount of allowance for credit loss on accounts receivable, classified as current.
Derivative Liabilities Current us-gaap/2025 0 0 monetary I C Derivative Liability, Current Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.
Gain Loss On Termination Of Lease us-gaap/2025 0 0 monetary D C Gain (Loss) on Termination of Lease Amount of gain (loss) on termination of lease before expiration of lease term.
Issuance Of Stock And Warrants For Services Or Claims us-gaap/2025 0 0 monetary D D Issuance of Stock and Warrants for Services or Claims Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2025 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
Common Stock Shares Issuable Per Share 0001213900-25-046026 1 0 perShare I Common Stock Shares Issuable Per Share Common stock issuable, shares issuable per share. .

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001213900-25-046026 2 3 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2025 Cash and cash equivalents 0
0001213900-25-046026 2 4 BS 0 H Accounts Receivable Net Current us-gaap/2025 Accounts receivable, net of allowance for doubtful accounts of $0 and $0, respectively 0
0001213900-25-046026 2 5 BS 0 H Inventory Net us-gaap/2025 Inventories, net 0
0001213900-25-046026 2 6 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2025 Prepaid expense and other current assets 0
0001213900-25-046026 2 7 BS 0 H Assets Current us-gaap/2025 Total current assets 0
0001213900-25-046026 2 8 BS 0 H Property Plant And Equipment Net us-gaap/2025 Property and equipment, net 0
0001213900-25-046026 2 9 BS 0 H Operating Lease Right Of Use Asset us-gaap/2025 Operating lease right-of-use asset 0
0001213900-25-046026 2 10 BS 0 H Other Assets Noncurrent us-gaap/2025 Other assets 0
0001213900-25-046026 2 11 BS 0 H Assets us-gaap/2025 Total assets 0
0001213900-25-046026 2 14 BS 0 H Accounts Payable Current us-gaap/2025 Accounts payable 0
0001213900-25-046026 2 15 BS 0 H Accrued Liabilities Current us-gaap/2025 Accrued expenses and current liabilities 0
0001213900-25-046026 2 16 BS 0 H Loans Payable To Bank Current us-gaap/2025 Loans payable to financial institutions, current 0
0001213900-25-046026 2 17 BS 0 H Loans Payable To Shareholders Current 0001213900-25-046026 Loans payable to others 0
0001213900-25-046026 2 18 BS 0 H Loan Payable Emergency Injury Disaster Loan E I D L Current 0001213900-25-046026 Loan payable, emergency injury disaster loan (EIDL), current 0
0001213900-25-046026 2 19 BS 0 H Loan Payable Payroll Protection Program P P P Current 0001213900-25-046026 Loan payable, payroll protection program (PPP), current 0
0001213900-25-046026 2 20 BS 0 H Convertible Debt Current us-gaap/2025 Convertible debt, net of debt discount of $ 3,142,146 and $0, respectively 0
0001213900-25-046026 2 21 BS 0 H Derivative Liabilities Current us-gaap/2025 Derivative Liability 0
0001213900-25-046026 2 22 BS 0 H Operating Lease Liability Current us-gaap/2025 Operating lease liabilities, current 0
0001213900-25-046026 2 23 BS 0 H Liabilities Current us-gaap/2025 Total current liabilities 0
0001213900-25-046026 2 24 BS 0 H Long Term Loans From Bank us-gaap/2025 Loans payable to financial institutions, net of current 0
0001213900-25-046026 2 25 BS 0 H Loan Payable Emergency Injury Disaster Loan Non Current 0001213900-25-046026 Loan payable, emergency injury disaster loan (EIDL), net of current 0
0001213900-25-046026 2 26 BS 0 H Loanpayablepayrollprotectionprogram P P P Non Current 0001213900-25-046026 Loan payable, payroll protection program (PPP), net of current 0
0001213900-25-046026 2 27 BS 0 H Operating Lease Liability Noncurrent us-gaap/2025 Operating lease liabilities, net of current 0
0001213900-25-046026 2 28 BS 0 H Liabilities us-gaap/2025 Total liabilities 0
0001213900-25-046026 2 29 BS 0 H Commitments And Contingencies us-gaap/2025 Commitments and Contingencies 0
0001213900-25-046026 6 13 CF 0 H Increase Decrease In Accrued Liabilities us-gaap/2025 Increase (decrease) in accrued liabilities, net 0
0001213900-25-046026 2 31 BS 0 H Common Stock Value us-gaap/2025 Common Stock, $0.0001 par value, 40,000,000 shares authorized; 4,274,508 and 4,274,508 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 0
0001213900-25-046026 2 32 BS 0 H Common Stock Issuable Value 0001213900-25-046026 Common stock issuable, $0.0001 par value, 294,000 shares issuable at $5.00 per share 0
0001213900-25-046026 2 33 BS 0 H Preferred Stock Value us-gaap/2025 Preferred Stock, $0.0001 par value, 1,000,000 shares authorized; no shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 0
0001213900-25-046026 2 34 BS 0 H Additional Paid In Capital us-gaap/2025 Additional paid-in capital 0
0001213900-25-046026 2 35 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2025 Accumulated deficit 0
0001213900-25-046026 2 36 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2025 Accumulated other comprehensive income (loss) 0
0001213900-25-046026 2 37 BS 0 H Stockholders Equity us-gaap/2025 Total stockholders equity 0
0001213900-25-046026 2 38 BS 0 H Liabilities And Stockholders Equity us-gaap/2025 Total liabilities and stockholders equity 0
0001213900-25-046026 3 1 BS 1 H Allowance For Doubtful Accounts Receivable Current us-gaap/2025 Accounts receivable, net of allowance for doubtful accounts (in Dollars) 0
0001213900-25-046026 3 2 BS 1 H Debt Instrument Unamortized Discount Current us-gaap/2025 Convertible debt, net of debt discount (in Dollars) 0
0001213900-25-046026 3 3 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2025 Common stock, par value (in Dollars per share) 0
0001213900-25-046026 3 4 BS 1 H Common Stock Shares Authorized us-gaap/2025 Common stock, shares authorized 0
0001213900-25-046026 3 5 BS 1 H Common Stock Shares Issued us-gaap/2025 Common stock, shares issued 0
0001213900-25-046026 3 6 BS 1 H Common Stock Shares Outstanding us-gaap/2025 Common stock, shares outstanding 0
0001213900-25-046026 3 7 BS 1 H Common Stock Issuables Par Value 0001213900-25-046026 Common stock issuable, par value (in Dollars per share) 0
0001213900-25-046026 3 8 BS 1 H Common Stock Issuable Share Issuable 0001213900-25-046026 Common stock issuable, shares issuable 0
0001213900-25-046026 3 9 BS 1 H Common Stock Shares Issuable Per Share 0001213900-25-046026 Common stock issuable, shares issuable per share (in Dollars per share) 0
0001213900-25-046026 3 10 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2025 Preferred stock, par value (in Dollars per share) 0
0001213900-25-046026 3 11 BS 1 H Preferred Stock Shares Authorized us-gaap/2025 Preferred stock, shares authorized 0
0001213900-25-046026 3 12 BS 1 H Preferred Stock Shares Issued us-gaap/2025 Preferred stock, shares issued 0
0001213900-25-046026 3 13 BS 1 H Preferred Stock Shares Outstanding us-gaap/2025 Preferred stock, shares outstanding 0
0001213900-25-046026 4 8 IS 0 H Revenues us-gaap/2025 Total net revenues 0
0001213900-25-046026 4 10 IS 0 H Other Cost And Expense Operating us-gaap/2025 Product, food and drink costs - stores 0
0001213900-25-046026 4 11 IS 0 H Cost Of Revenue us-gaap/2025 Cost of saleswholesale and online 0
0001213900-25-046026 4 12 IS 0 H General And Administrative Expense us-gaap/2025 General and administrative 0
0001213900-25-046026 4 13 IS 0 H Operating Costs And Expenses us-gaap/2025 Total operating costs and expenses 0
0001213900-25-046026 4 14 IS 0 H Operating Income Loss us-gaap/2025 Loss from operations 0
0001213900-25-046026 4 16 IS 0 H Other Nonoperating Income Expense us-gaap/2025 Other income (expense) 0
0001213900-25-046026 4 17 IS 0 H Derivative Expense 0001213900-25-046026 Derivative Expense 1
0001213900-25-046026 4 18 IS 0 H Interest Expense Nonoperating us-gaap/2025 Interest expense 1
0001213900-25-046026 4 19 IS 0 H Nonoperating Income Expense us-gaap/2025 Total other expense, net 0
0001213900-25-046026 4 20 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2025 Loss before income taxes 0
0001213900-25-046026 4 21 IS 0 H Income Tax Expense Benefit us-gaap/2025 Provision for income taxes 0
0001213900-25-046026 4 22 IS 0 H Net Income Loss us-gaap/2025 Net loss 0
0001213900-25-046026 4 24 IS 0 H Earnings Per Share Basic us-gaap/2025 Basic (in Dollars per share) 0
0001213900-25-046026 4 25 IS 0 H Earnings Per Share Diluted us-gaap/2025 Diluted (in Dollars per share) 0
0001213900-25-046026 4 27 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2025 Basic (in Shares) 0
0001213900-25-046026 4 28 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2025 Diluted (in Shares) 0
0001213900-25-046026 5 11 EQ 0 H Stockholders Equity us-gaap/2025 Balance 0
0001213900-25-046026 5 12 EQ 0 H Shares Outstanding us-gaap/2025 Balance (in Shares) 0
0001213900-25-046026 5 13 EQ 0 H Net Income Loss us-gaap/2025 Net loss 0
0001213900-25-046026 5 14 EQ 0 H Stock Issued During Period Value Conversion Of Units us-gaap/2025 Common stock issued 0
0001213900-25-046026 5 15 EQ 0 H Stock Issued During Period Shares Conversion Of Units us-gaap/2025 Common stock issued (in Shares) 0
0001213900-25-046026 5 16 EQ 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2025 Foreign currency translation 0
0001213900-25-046026 5 17 EQ 0 H Stockholders Equity us-gaap/2025 Balance 0
0001213900-25-046026 5 18 EQ 0 H Shares Outstanding us-gaap/2025 Balance (in Shares) 0
0001213900-25-046026 6 2 CF 0 H Net Income Loss us-gaap/2025 Net loss 0
0001213900-25-046026 6 4 CF 0 H Issuance Of Stock And Warrants For Services Or Claims us-gaap/2025 Debt Discount Expense 0
0001213900-25-046026 6 5 CF 0 H Gain Loss On Termination Of Lease us-gaap/2025 Operating lease 1
0001213900-25-046026 6 6 CF 0 H Derivative Expense 0001213900-25-046026 Derivative Expense 0
0001213900-25-046026 6 7 CF 0 H Depreciation us-gaap/2025 Depreciation 0
0001213900-25-046026 6 9 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2025 Decrease (increase) in accounts receivable 1
0001213900-25-046026 6 10 CF 0 H Increase Decrease In Inventories us-gaap/2025 Decrease (increase) in inventories 1
0001213900-25-046026 6 11 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2025 Decrease (increase) in other assets, net 1
0001213900-25-046026 6 12 CF 0 H Increase Decrease In Accounts Payable us-gaap/2025 Increase (decrease) in accounts payable 0
0001213900-25-046026 6 14 CF 0 H Increase Decrease In Derivative Liabilities us-gaap/2025 Increase (decrease) in derivative liability 0
0001213900-25-046026 6 15 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2025 Net cash used in operating activities 0
0001213900-25-046026 6 17 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2025 Acquisition of property and equipment 1
0001213900-25-046026 6 18 CF 0 H Proceeds From Sale Of Productive Assets us-gaap/2025 Proceeds from sale of assets 0
0001213900-25-046026 6 19 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2025 Net cash used in investing activities 0
0001213900-25-046026 6 21 CF 0 H Proceeds From Issuance Of Common Stock us-gaap/2025 Proceeds from issuance of common stock 0
0001213900-25-046026 6 22 CF 0 H Repayment Of Borrowings From Shareholder 0001213900-25-046026 Repayment of borrowings from shareholder 0
0001213900-25-046026 6 23 CF 0 H Proceeds From Repayments Of Other Debt us-gaap/2025 (Repayment) Proceeds from loan payable to others 0
0001213900-25-046026 6 24 CF 0 H Repayments Of Short Term Debt us-gaap/2025 Repayment of loans 1
0001213900-25-046026 6 25 CF 0 H Repayent Of Loan Payable Public Private Partnership 0001213900-25-046026 Repayment of loan payable, PPP 1
0001213900-25-046026 6 26 CF 0 H Proceeds From Notes Payable us-gaap/2025 Borrowings from convertible notes payable 0
0001213900-25-046026 6 27 CF 0 H Repayments Of Notes Payable us-gaap/2025 Adjustment of Debt Discount for Notes Payable 1
0001213900-25-046026 6 28 CF 0 H Proceeds From Repayments Of Notes Payable us-gaap/2025 Repayments of loan payable to financial institutions 0
0001213900-25-046026 6 29 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2025 Net cash provided by financing activities 0
0001213900-25-046026 6 30 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect us-gaap/2025 Net increase (decrease) in cash 0
0001213900-25-046026 6 31 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Cash at beginning of year 0
0001213900-25-046026 6 32 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2025 Cash at end of year 0
0001213900-25-046026 6 34 CF 0 H Debt Conversion Converted Instrument Amount1 us-gaap/2025 Conversion of credit line to common stock issuances 0
0001213900-25-046026 6 37 CF 0 H Right Of Use Asset Obtained In Exchange For Operating Lease Liability us-gaap/2025 Lease liabilities 0
0001213900-25-046026 6 38 CF 0 H Interest Paid Net us-gaap/2025 Interest 0
0001213900-25-046026 6 39 CF 0 H Income Taxes Paid Net us-gaap/2025 Income taxes 1

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.